NEUPOGEN LV Trademark

Trademark Overview

On Tuesday, September 27, 2005, a trademark application was filed for NEUPOGEN LV with the United States Patent and Trademark Office. The USPTO has given the NEUPOGEN LV trademark a serial number of 78721746. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 28, 2009. This trademark is owned by Amgen Inc.. The NEUPOGEN LV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in stimulating white blood cell production; prefilled syringe containing pharmaceutical preparations for use in stimulating white blood cell production
neupogen lv

General Information

Serial Number78721746
Word MarkNEUPOGEN LV
Filing DateTuesday, September 27, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 28, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2006

Trademark Statements

Disclaimer with Predetermined Text"LV"
Goods and ServicesPharmaceutical preparations for use in stimulating white blood cell production; prefilled syringe containing pharmaceutical preparations for use in stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, September 28, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 28, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 14, 2009ASSIGNED TO EXAMINER
Monday, February 9, 2009EXTENSION 5 GRANTED
Thursday, February 5, 2009EXTENSION 5 FILED
Thursday, February 5, 2009TEAS EXTENSION RECEIVED
Monday, August 11, 2008EXTENSION 4 GRANTED
Wednesday, July 30, 2008EXTENSION 4 FILED
Monday, August 11, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 30, 2008TEAS EXTENSION RECEIVED
Wednesday, February 13, 2008EXTENSION 3 GRANTED
Wednesday, January 30, 2008EXTENSION 3 FILED
Wednesday, January 30, 2008TEAS EXTENSION RECEIVED
Thursday, September 20, 2007EXTENSION 2 GRANTED
Wednesday, August 8, 2007EXTENSION 2 FILED
Wednesday, August 8, 2007TEAS EXTENSION RECEIVED
Friday, May 25, 2007EXTENSION 1 GRANTED
Tuesday, February 27, 2007EXTENSION 1 FILED
Tuesday, February 27, 2007TEAS EXTENSION RECEIVED
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 29, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2006PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2006NOTICE OF PUBLICATION
Wednesday, April 12, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 7, 2006ASSIGNED TO LIE
Monday, April 3, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 3, 2006EXAMINER'S AMENDMENT ENTERED
Monday, April 3, 2006EXAMINERS AMENDMENT E-MAILED
Monday, April 3, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, March 30, 2006ASSIGNED TO EXAMINER
Monday, October 3, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

neupogen cell production pharmaceutical blood white preparations stimulating containing prefilled syringe